Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Arbor Realty Trust
ABR
$950M
| $4.51M | 0.01% |
605,000
+247,500
| +69% | +$1.82M |
|
|
CUK
1727
DELISTED
Carnival PLC
CUK
| $4.51M | 0.01% |
88,100
+58,900
| +202% | +$2.93M |
|
1728
Angi Inc
ANGI
$191M
| $4.5M | 0.01% |
54,700
-13,790
| -20% | -$1.18M |
|
|
GSH
1729
DELISTED
Guangshen Railway Co. Ltd
GSH
| $4.49M | 0.01% |
148,100
+4,600
| +3% | +$127K |
|
|
CNCE
1730
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.48M | 0.01% |
435,800
+112,396
| +35% | +$1.03M |
|
1731
Alamos Gold
AGI
$14B
| $4.48M | 0.01% |
652,129
+349,569
| +116% | +$2.46M |
|
|
PEGI
1732
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $4.48M | 0.01% |
236,000
+94,400
| +67% | +$1.94M |
|
|
ONIT
1733
Onity Group
ONIT
$328M
| $4.47M | 0.01% |
55,353
-1,960
| -3% | -$138K |
|
|
WES
1734
DELISTED
Western Gas Partners Lp
WES
| $4.47M | 0.01% |
76,100
-55,800
| -42% | -$3.14M |
|
|
AVHI
1735
DELISTED
A V Homes, Inc.
AVHI
| $4.47M | 0.01% |
282,700
+63,300
| +29% | +$1.02M |
|
|
CSLT
1736
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.47M | 0.01% |
902,190
+102,690
| +13% | +$465K |
|
1737
Park-Ohio Holdings
PKOH
$716M
| $4.46M | 0.01% |
104,700
+21,000
| +25% | +$806K |
|
1738
Travelzoo
TZOO
$73.4M
| $4.46M | 0.01% |
474,100
+19,000
| +4% | +$211K |
|
|
AFAM
1739
DELISTED
Almost Family Inc
AFAM
| $4.45M | 0.01% |
101,000
+58,100
| +135% | +$2.37M |
|
|
DALN
1740
DELISTED
DallasNews
DALN
| $4.45M | 0.01% |
175,147
+16,122
| +10% | +$420K |
|
|
KE
1741
Kimball Electronics
KE
$622M
| $4.43M | 0.01% |
243,375
-20,300
| -8% | -$326K |
|
|
SMMF
1742
DELISTED
Summit Financial Group, Inc.
SMMF
| $4.42M | 0.01% |
160,635
+38,000
| +31% | +$892K |
|
|
CXP
1743
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $4.42M | 0.01% |
204,700
-79,100
| -28% | -$1.69M |
|
1744
AXT Inc
AXTI
$5.34B
| $4.41M | 0.01% |
918,834
+6,738
| +0.7% | +$34.7K |
|
|
VLP
1745
DELISTED
Valero Energy Partners LP
VLP
| $4.4M | 0.01% |
99,442
+72,242
| +266% | +$2.99M |
|
|
UMPQ
1746
DELISTED
Umpqua Holdings Corp
UMPQ
| $4.4M | 0.01% |
234,278
-40,522
| -15% | -$690K |
|
|
WCC
1747
WESCO International
WCC
$17.6B
| $4.4M | 0.01% |
+66,100
| New | +$4.2M |
|
|
NP
1748
DELISTED
Neenah, Inc. Common Stock
NP
| $4.39M | 0.01% |
51,500
+42,400
| +466% | +$3.51M |
|
|
VTLE
1749
DELISTED
Vital Energy
VTLE
| $4.38M | 0.01% |
+15,495
| New | +$4.26M |
|
1750
First Northwest Bancorp
FNWB
$109M
| $4.37M | 0.01% |
280,200
+163,000
| +139% | +$2.38M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.